Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Eledon Pharma, Lowers Price Target to $26

SVB Leerink analyst Thomas Smith maintains Eledon Pharma (NASDAQ:ELDN) with a Outperform and lowers the price target from $33 to $26.
byBenzinga Newsdesk
June 1, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Thomas Smith maintains Eledon Pharma (NASDAQ:ELDN) with a Outperform and lowers the price target from $33 to $26.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0